Background: A disorganization factor was found by several factor-analytic studies of schizophrenia symptoms. This factor does not appear to be affected by age, severity of other symptoms and chronicity of illness. A greater severity of disorganization is associated with poor functioning. Despite the general similarity of different factorial model, there is no consensus about which symptoms have to be included in the disorganization factor. Using the Positive and Negative Syndrome Scale (PANSS), Conceptual disorganization' (P2), 'Difficulty in abstract thinking' (N5) and 'Poor attention' (G11) were core features of the disorganization factor. The overlap of these items with neurocognitive functions is still debated. However, the heterogeneity of this factor and its neurobiological basis should be further investigated.
In the context of the multicenter study of the Italian Network for Research on Psychoses, the main aims of our study were to investigate electrophysiological and neurocognitive correlates of the disorganization factor, and to assess if each PANSS item, loading on the disorganization factor, could be underpinned by similar electrophysiological or cognitive alterations.
Methods:
Resting state EEGs were recorded for 5 minutes in 145 stabilized subjects with schizophrenia (SCZ) and 69 matched healthy controls (HC). The disorganization factor was evaluated using three PANSS items: P2, N5, and G11 (4). Neurocognitive functions were assessed using the MATRICS Consensus Cognitive Battery (MCCB). Spectral amplitude was quantified in nine frequency bands. All statistical analyses of the scalp multichannel spectral amplitude (SAmp) data were performed using RAGU software. Statistical comparisons between the SAmp maps of SCZ and HC were assessed by topographic analyses of variance (TANOVA). In SCZ, topographic analyses of covariance (TANCOVA) evaluated correlations between SAmp and disorganization, its constituent items and MCCB domains. Furthermore, Pearson's correlations were performed between disorganization and its constituent items and MCCB neurocognitive domains. Results: TANOVA, comparing the group SAmp maps revealed increased Delta, Theta, and Beta1 and decreased Alpha2 SAmp in SCZ. In the SCZ group, disorganization was significantly correlated to the Alpha1 SAmp. This relation was negative and most pronounced at occipital sites. At the items level, only N5 showed the same negative correlation at occipital sites. MCCB neurocognitive composite score was associated with disorganization factor, and its constituent items P2 and N5. No significant correlation between Alpha1 SAmp and MCCB cognitive domains was observed. Discussion: Our findings illustrate the heterogeneity of disorganization dimension and a partial overlap with neurocognitive domains. 'Difficulty in abstract thinking' showed a unique association with Alpha1 activity, which is thought to be involved in the construction of conceptual maps. Furthermore, the observed association of Alpha1 with 'Difficulty in abstract thinking' suggests that some aspects of disorganization could be underpinned by the impairment of basic neurobiological functions that are only partially evaluated using MCCB. Background: Many studies have highlighted the similarity of the symptoms between bipolar disorders and schizophrenia. Moreover, there are no pathognomonic symptoms that can differentiate these two disorders, and 9% of schizophrenia patients have experienced a manic syndrome in their lifetime. Insight about their symptoms and illness is very important factor for the differential diagnosis and the management in schizophrenia. To examine the relationship among the insight, the psychotic and manic symptoms, and clinical variables in patients with chronic schizophrenia. Methods: Seventy-four participants (male 44, female 30) with chronic schizophrenia in community mental health facilities have been evaluated with the Scale to assess Unawareness of Mental Disorder (SUMD), the Mood Disorder Questionnaire (MDQ), and the Brief Psychiatric Rating Scale (BPRS). Results: The mean number of previous admission was 3.85. Their drug adherence was favorable (6.73 day/week). Mean CGI-S score was 3.8. Thirty-five percent of subject were MDQ positive (cutoff point = 7 or more). Among SUMD, "awareness of effect of medication" showed significant negative correlation (r = -0.33) with total MDQ score not with total BPRS score. The negative correlation was more obvious in participants with negative MDQ (total MDQ score 6 or less, r = -0.31). Several MDQ items (irritability, r = -0.25; decreased sleep, r = -0.27; thought racing, r = -0.28; and easy distractibility, r = -0.40) negatively correlated with "awareness of effect of medication". In contrast, only one item (guilt feeling, r = -0.27) of BPRS revealed this correlation. Individual items in MDQ and BPRS rarely correlated with each other. Total MDQ score was not correlated with duration of illness and medication adherence. Discussion: Manic symptoms were frequently detected even in schizophrenia as reported in previous studies. This made it difficult to differentially diagnose the disorder using only the total MDQ score. There was possible relationship between these manic symptoms and their insight. Identifying manic symptoms in schizophrenia would be considerable in clinical setting. Background: It is important to have extensive knowledge of the patients with schizophrenia, to provide the right support in outpatient care to create a good situation for the patient and prevent hospitalization. Lack of insight regarding the illness and symptoms might impair the patient's ability to understand the illness, the treatment and relapses into psychotic episodes. Symptomatic remission is a well-established goal for treatment. If the core-symptoms do not affect their functions and the status is stable for at least six months, the patient is in remission. Previous research has shown an increased remission status from approximately 30% to more than 50% after using standardized remission criteria for patients with schizophrenia in Sweden. This study aims to investigate the relationship between both insight of symptoms and illness insight with cross-sectional remission.
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Methods: This is a cross-sectional study and the participants consisted of totally 289 patients with schizophrenia diagnosis. Of the participants 111 were women and 178 were men, with a mean age of 47 years (19-83 years old). Using semi-structured interviews and evidence-based assessment scales Remission Scale -Symptom (RS-S) and Psychosis Evaluation Tool for Common use by Caregivers (PECC) the data is collected. Cross tabulations were used to compare the distribution of the variables and the Pearson Chi-Square Tests for examine significant association.
Results: Insight of symptom:
The results show that from the patients who are not in remission, 69.5% are missing insight to symptoms, while 30.5% are having insight of symptoms. When it comes to the patients within remission, 59.0% have an insight of symptoms, while 41.0% are missing this sort of insight. The findings in the analysis with Chi-Square Tests examine independence indicated significant association between insight of symptoms and remission status (1, x2 = 22.17), p = <0,001, phi = -0.28. Insight of illness: During the analysis of insight of illness, the results show that from the patients who are in remission, 61.9% possess insight of illness, compared to 38.1% of the patients lacking insight of illness. Concerning the insight of illness for the patients who are not in remission, 68.2% lack insight of illness, while 31.8% possess insight of illness. The Chi-Square Tests examine independence indicated significant association between insight of illness and remission status (1, x2 = 24.28), p = <0.001, phi = -0. Background: People diagnosed with schizophrenia spectrum illnesses report higher levels of internalized stigma in comparison to other mental health diagnoses (Holzinger, Beck, Munk, Weithaas, & Angermeyer, 2003) . Studies have shown high overlap between depression and symptoms of schizotypy in nonclinical adolescents (Fonseca-Pedrero, Paino, LemosGiráldez, & Muñiz, 2011) , but the role that stigma plays in this relationship has yet to be examined. This is of importance because it can be targeted (Rüsch, Angermeyer, & Corrigan, 2005) and prior literature has found that awareness campaigns to reduce stigma can improve psychological functioning (Mittal, Sullivan, Chekuri, Allee, & Corrigan, 2012) . Based on previous literature, we predict that schizotypal personality traits will be related to symptoms of depression, anxiety and stress (DASS), and that these will both be related to internalized stigma.
Methods:
The current study is a sample of 494 college students who completed surveys to assess for schizotypal personality traits (SPQ; Raine, 1991), depression, anxiety and stress (Depression Anxiety Stress Scales DASS; Lovibond & Lovibond, 1995) , and internalized stigma (ISMI; Boyd, Otilingam, & DeForge, 2014) . Results: Correlation coefficients indicated that higher endorsement of schizotypal personality was associated with greater DASS scores (r=.645; p<.01) and internalized stigma (r=.406; p<01). A multiple regression was conducted regressing SPQ on ISMI and DASS, F (2,491) = 183.949, p<.01, R2=.428. Controlling for ISMI scores, DASS was predictive of higher schizotypal personality ratings (Beta=.586; p<01). Controlling for DASS, ISMI scores were also predictive of schizotypal personality (Beta=.123; p=.002). Discussion: As hypothesized, schizotypy, DASS, and internalized stigma were all positively associated. Internalized stigma could lead to symptoms of depression, anxiety and stress as well as schizotypy. It is possible that internalized stigma plays its own unique role in the onset of schyzotypy. This study is limited by the self-report and cross-sectional nature.
Longitudinal studies are necessary to further assess causality in these variables. Screening for schizotypal personality traits when patients present for symptoms of depression and anxiety could be useful in early intervention
